<SEC-DOCUMENT>0001553350-16-001866.txt : 20160408
<SEC-HEADER>0001553350-16-001866.hdr.sgml : 20160408
<ACCEPTANCE-DATETIME>20160408132718
ACCESSION NUMBER:		0001553350-16-001866
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20160408
DATE AS OF CHANGE:		20160408

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apollo Medical Holdings, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		IRS NUMBER:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-84072
		FILM NUMBER:		161562211

	BUSINESS ADDRESS:	
		STREET 1:		450 NORTH BRAND BLVD.,
		STREET 2:		SUITE 600
		CITY:			GLENDALE
		STATE:			CA
		ZIP:			91203
		BUSINESS PHONE:		818-396-8050

	MAIL ADDRESS:	
		STREET 1:		700 NORTH BRAND BLVD.,
		STREET 2:		SUITE 1400
		CITY:			GLENDALE
		STATE:			CA
		ZIP:			91203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Network Medical Management, Inc.
		CENTRAL INDEX KEY:			0001656434
		IRS NUMBER:				954472349

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVE., 2ND FL.
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801
		BUSINESS PHONE:		(626) 943-6238

	MAIL ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVE., 2ND FL.
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>nnm_sc13d.htm
<DESCRIPTION>SC 13D/A
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>SC 13D/A</TITLE>
<META NAME="author" CONTENT="EDGAR FILING &nbsp;LLC">
<META NAME="date" CONTENT="10/26/2015">
</HEAD>
<BODY style="margin-top:0;font-family:Times New Roman; font-size:10pt; color:#000000">
<P style="margin:0px" align=center><BR></P>
<P style="margin-top:0px; margin-bottom:2.067px; padding-bottom:4px; border-bottom:4px solid #000000" align=right>&nbsp;</P>
<P style="margin:0px; padding-top:4px; border-top:1.333px solid #000000" align=right>&nbsp;</P>
<P style="margin:0px" align=center><B>UNITED STATES </B></P>
<P style="margin:0px" align=center><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P style="margin:0px" align=center><B>Washington, D.C. 20549</B></P>
<P style="line-height:8pt; margin:0px">&nbsp;</P>
<P style="margin:0px" align=center>&#151;&#151;&#151;&#151;&#151;&#151;&#151;</P>
<P style="margin:0px" align=center><B>SCHEDULE 13D</B></P>
<P style="margin:0px" align=center>&#151;&#151;&#151;&#151;&#151;&#151;&#151;</P>
<P style="line-height:8pt; margin:0px">&nbsp;</P>
<P style="margin:0px" align=center><B>Under the Securities Exchange Act of 1934</B></P>
<P style="margin:0px" align=center>(Amendment No. 1)<SUP>*</SUP></P>
<P style="line-height:8pt; margin:0px"><BR></P>
<P style="margin:0px; font-size:12pt" align=center><B>Apollo Medical Holdings, Inc.</B></P>
<P style="margin:0px; font-size:8pt" align=center><I>(Name of Issuer)</I></P>
<P style="line-height:8pt; margin:0px"><BR></P>
<P style="margin:0px" align=center><B>Common Stock</B></P>
<P style="margin:0px; font-size:8pt" align=center><I>(Title of Class of Securities)</I></P>
<P style="line-height:8pt; margin:0px">&nbsp;</P>
<P style="margin:0px" align=center><B>03763A207</B></P>
<P style="margin:0px; font-size:8pt" align=center><I>(CUSIP Number)</I></P>
<P style="line-height:8pt; margin:0px">&nbsp;</P>
<P style="margin:0px" align=center><B>Tin Kin Lee, Esq.</B></P>
<P style="margin:0px" align=center><B>1811 Fair Oaks Avenue</B></P>
<P style="margin:0px" align=center><B>South Pasadena, CA 91030</B></P>
<P style="margin:0px" align=center><B>(626) 229-9828</B></P>
<P style="margin:0px; font-size:8pt" align=center><I>(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)</I></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>March 30, 2016</B></P>
<P style="margin:0px; font-size:8pt" align=center><I>(Date of Event which Requires Filing of this Statement)</I></P>
<P style="line-height:8pt; margin:0px"><BR></P>
<P style="margin:0px">If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of &#167;&#167;240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.&nbsp;<FONT style="font-family:Wingdings">&#168;</FONT></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><B>Note</B>: &nbsp;Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule&nbsp;13d-7 for other parties to whom copies are to be sent.</P>
<P style="line-height:8pt; margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=6.667 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=6.667><P style="margin:0px">*</P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px">The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.</P>
</TD></TR>
</TABLE>
<P style="line-height:8pt; margin:0px; font-size:12pt">&nbsp;</P>
<P style="margin:0px">The information required on the remainder of this cover page shall not be deemed to be &quot;filed&quot; for the purpose of Section 18 of the Securities Exchange Act of 1934 (&quot;Act&quot;) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin-top:0px; margin-bottom:2.067px; padding-bottom:4px; border-bottom:1.333px solid #000000">&nbsp;&nbsp;</P>
<P style="margin:0px; padding-top:4px; border-top:4px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P style="margin:0px"><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=177.6 /><TD /><TD width=177.533 /></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" width=177.6><P style="margin:0px">CUSIP No.&nbsp; <B>03763A207</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF"><P style="margin:0px" align=center><B>13D</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" width=177.533><P style="margin:0px" align=right>Page&nbsp;2&nbsp;of&nbsp;5 Pages</P>
</TD></TR>
</TABLE>
<P style="margin:0px; font-size:12pt">&nbsp;</P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=48.267 /><TD width=136.067 /><TD width=2.733 /><TD width=29.267 /><TD /></TR>
<TR><TD style="margin-top:0px; border:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>1</B></P>
</TD><TD style="margin-top:0px; border-top:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">NAME OF REPORTING PERSONS</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:3.2px"><B>Network Medical Management, Inc.</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>2</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</P>
<P style="margin:0px; padding-left:3.2px">(a)&nbsp;&nbsp; <FONT style="font-family:Wingdings">&#168;</FONT></P>
<P style="margin:0px; padding-left:3.2px">(b)&nbsp;&nbsp; <FONT style="font-family:Wingdings">&#254;</FONT></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>3</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">SEC USE ONLY</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>4</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">SOURCE OF FUNDS</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
<P style="margin:0px; padding-left:3.2px"><B>BK; WC</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>5</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS&nbsp;2(d) OR 2(e)</P>
<P style="margin:0px; padding-left:3.2px; font-family:Wingdings">&#168;</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>6</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">CITIZENSHIP OR PLACE OF ORGANIZATION</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
<P style="margin:0px; padding-left:3.2px"><B>California</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-bottom:1px solid #000000" width=48.267 rowspan=4><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-bottom:1px solid #000000" width=136.067 rowspan=4><P style="margin:0px; padding-left:8.067px" align=center><B>NUMBER OF</B></P>
<P style="margin:0px; padding-left:8.067px" align=center><B>SHARES</B></P>
<P style="margin:0px; padding-left:8.067px" align=center><B>BENEFICIALLY</B></P>
<P style="margin:0px; padding-left:8.067px" align=center><B>OWNED BY EACH</B></P>
<P style="margin:0px; padding-left:8.067px" align=center><B>REPORTING</B></P>
<P style="margin:0px; padding-left:8.067px" align=center><B>PERSON WITH:</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000" width=2.733><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=29.267><P style="margin:0px" align=center><B>7</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top><P style="margin:0px; padding-left:3.2px">SOLE VOTING POWER</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
<P style="margin:0px; padding-left:3.2px"><B>3,333,332</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-right:1px solid #000000" width=2.733><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=29.267><P style="margin:0px" align=center><B>8</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top><P style="margin:0px; padding-left:3.2px">SHARED VOTING POWER</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:3.2px"><B>0</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-right:1px solid #000000" width=2.733><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=29.267><P style="margin:0px" align=center><B>9</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top><P style="margin:0px; padding-left:3.2px">SOLE DISPOSITIVE POWER</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
<P style="margin:0px; padding-left:3.2px"><B>3,333,332</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" width=2.733><P style="margin:0px; padding:0px">&nbsp;</P></TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=29.267><P style="margin:0px" align=center><B>10</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top><P style="margin:0px; padding-left:3.2px">SHARED DISPOSITIVE POWER</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:3.2px"><B>0</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>11</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:3.2px"><B>3,333,332</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>12</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:3.2px; font-family:Wingdings">&#168;</P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>13</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:3.2px"><B>36.7%</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; border-left:1px solid #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=48.267><P style="margin:0px" align=center><B>14</B></P>
</TD><TD style="margin-top:0px; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=top width=672.4 colspan=4><P style="margin:0px; padding-left:3.2px">TYPE OF REPORTING PERSON</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; padding-left:3.2px"><B>CO</B></P>
<P style="margin:0px; padding-left:3.2px">&nbsp;</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=177.6 /><TD /><TD width=177.533 /></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" width=177.6><P style="margin:0px">CUSIP No.&nbsp; <B>03763A207</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF"><P style="margin:0px" align=center><B>13D</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" width=177.533><P style="margin:0px" align=right>Page&nbsp;3&nbsp;of&nbsp;5 Pages</P>
</TD></TR>
</TABLE>
<P style="margin:0px; font-size:12pt">&nbsp;</P>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=96.067 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=96.067><P style="margin:0px"><B>ITEM&nbsp;1.&nbsp;&nbsp;</B></P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px"><B>SECURITY AND ISSUER</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px">The name of the issuer is Apollo Medical Holdings, Inc., a Delaware corporation (&#147;Issuer&#148;), which has its principal executive offices at 700 N. Brand Blvd., Suite 220, Glendale, CA 91203. This statement relates to the Issuer&#146;s class of common stock, $.001 par value per share (&#147;Common Stock&#148;).</P>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=96.067 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=96.067><P style="margin:0px"><B>ITEM&nbsp;2.&nbsp;&nbsp;</B></P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px"><B>IDENTITY AND BACKGROUND</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px">This statement is filed by Network Medical Management, Inc., a California corporation (the &#147;Reporting Person&#148;), whose principal office is located at 1668 S. Garfield Ave., 2nd Floor, Alhambra, CA 91801. &nbsp;The principal business of the Reporting Person is providing management and administrative services to medical groups, independent physician practice associations and other healthcare organizations.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">During the last five years, the Reporting Person has not been convicted in a criminal proceeding.</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">In addition, during the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which it was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</P>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=96.067 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=96.067><P style="margin:0px"><B>ITEM&nbsp;3.&nbsp;&nbsp;</B></P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px"><B>SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="line-height:11pt; margin:0px; padding-right:-0.933px">Pursuant to a Securities Purchase Agreement dated October 14, 2015, by and among the Issuer and the Reporting Person, the Reporting Person purchased beneficial ownership of 2,222,222 shares of Issuer&#146;s Common Stock. &nbsp;100% of the funds used by the Reporting Person to purchase beneficial ownership of shares of the Issuer&#146;s Common Stock was obtained from a bank loan/line of credit, which was made in the ordinary course of business by a FDIC&#173;insured bank (see Exhibit A). The total funds borrowed under the bank line of credit to acquire such beneficial ownership was $10 million. The Reporting Person has identified the name of the Reporting Person&#146;s bank to the Secretary of the Commission and requested that the name of such bank not be made available to the public.</P>
<P style="line-height:11pt; margin:0px"><BR></P>
<P style="line-height:11pt; margin:0px">Pursuant to a Securities Purchase Agreement dated March 30, 2016, by and among the Issuer and the Reporting Person, the Reporting Person purchased beneficial ownership of 1,111,110 shares of Issuer&#146;s Common Stock. &nbsp;100% of the funds used by the Reporting Person to purchase beneficial ownership of shares of Company&#146;s Common Stock was obtained from cash reserves of the Reporting Person. &nbsp;The total funds used to acquire such beneficial ownership was $4,999,995.&nbsp;</P>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=96.067 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=96.067><P style="margin:0px"><B>ITEM&nbsp;4.&nbsp;&nbsp;</B></P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px"><B>PURPOSE OF TRANSACTION.</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="line-height:11pt; margin:0px">The Reporting Person believes that the purchase of beneficial ownership of shares of the Issuer&#146;s Common Stock represents an attractive investment and potentially attractive business opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Person, and the availability of shares of the Issuer&#146;s Common Stock at prices that would make the purchase of additional shares desirable, the Reporting Person may endeavor to increase its position in the Issuer through, among other things, the purchase of additional shares of the Issuer&#146;s Common Stock on the open market or in private transactions, at such time and on such terms as the Reporting Person may deem advisable.</P>
<P style="line-height:11pt; margin:0px"><BR></P>
<P style="line-height:11pt; margin:0px">The Reporting Person does not have any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a)&#173;(j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon completion of any of the actions discussed above. The Reporting Person intends to review its investment in the Issuer on a continuing basis and engage in discussions with management and the Board of Directors of the Issuer concerning the business, operations and future plans of the Issuer.</P>
<P style="line-height:11pt; margin:0px"><BR></P>
<P style="line-height:11pt; margin:0px">The Reporting Person is regularly reviewing the Issuer&#146;s publicly announced business plans, as stated in the Issuer&#146;s press releases and SEC filings. Depending upon various factors, including without limitation, the Issuer&#146;s financial position and investment strategy, the price levels of the shares of the Issuer&#146;s Common Stock, conditions in the securities market and general economic and industry conditions, the Reporting Person may in the future take such actions with respect to its investment in the Issuer as it deems appropriate, including without limitation, purchasing additional shares of the Issuer&#146;s Common Stock, selling some or all of its shares of the Issuer&#146;s Common Stock, effectuating a merger or other business combination, or changing its intention with respect to any and all matters referred to in this Item 4.</P>
<P style="margin:0px"><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=177.6 /><TD /><TD width=177.533 /></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" width=177.6><P style="margin:0px">CUSIP No.&nbsp; <B>03763A207</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF"><P style="margin:0px" align=center><B>13D</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" width=177.533><P style="margin:0px" align=right>Page&nbsp;4&nbsp;of&nbsp;5 Pages</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=96.067 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=96.067><P style="margin:0px"><B>ITEM&nbsp;5.&nbsp;&nbsp;</B></P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px"><B>INTEREST IN SECURITIES OF THE ISSUER.</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">(a)</P>
<P style="margin:0px; text-indent:-2px">As of the date of this report, the Reporting Person beneficially owned a total of 3,333,332 shares of Common Stock of the Issuer, which is approximately 36.7% of the class of Common Stock, as calculated in accordance with Rule 13d&#173;3 under the Securities Exchange Act of 1934. The Common Stock beneficially owned includes 1,111,111 shares of Common Stock that may be acquired upon conversion of Series A Preferred Stock that is currently convertible, 555,555 shares of Common Stock that may be acquired upon conversion of Series B Preferred Stock that is currently convertible, and 1,666,666 shares of Common Stock that may be acquired upon exercise of currently exercisable warrants. Rule 13d&#173;3 provides, in part, that shares are deemed to be beneficially owned by a person if the person has the right to acquire the shares (for example, upon conversion of preferred stock or exercise of an option or warrant) within 60 days. In computing the percentage ownership of any person under Rule 13d&#173;3, the amount of shares outstanding is deemed to include the number of shares beneficially owned by such person (and only such person) by reason of these acquisition rights. As a result, the percentage of outstanding shares of the person does not necessarily reflect a person&#146;s actual ownership or voting power with respect to the number of shares of Common Stock actually outstanding. According to the Issuer&#146;s most recent quarterly report, which was filed with the Securities and Exchange Commission on February 16, 2016, the Issuer had 5,738,389 shares of Common Stock issued and outstanding as of February 12, 2016.</P>
<P style="margin:0px; clear:left"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">(b)</P>
<P style="margin:0px; text-indent:-2px">The Reporting Person has sole voting and dispositive power with respect to the securities of the Issuer beneficially owned by the Reporting Person.</P>
<P style="margin:0px; clear:left"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">(c)</P>
<P style="margin:0px; text-indent:-2px">There were no transactions involving Common Stock that were affected by the Reporting Person during the past sixty days.</P>
<P style="margin:0px; clear:left"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">(d)</P>
<P style="margin:0px; text-indent:-2px">No person other than the Reporting Person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities beneficially owned by the Reporting Person.</P>
<P style="margin:0px; clear:left"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">(e)</P>
<P style="margin:0px; text-indent:-2px">Item 5(e) is not applicable.</P>
<P style="margin:0px; font-size:12pt; clear:left">&nbsp;</P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=96.067 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=96.067><P style="margin:0px"><B>ITEM&nbsp;6.&nbsp;&nbsp;</B></P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px"><B>CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px; text-indent:48px; font-size:12pt">&nbsp;</P>
<P style="margin:0px">The information required by this Item 6 is provided in Items 3, 4 and 7 of this Statement.</P>
<P style="margin:0px"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=96.067 /><TD /></TR>
<TR><TD style="margin-top:0px" valign=top width=96.067><P style="margin:0px"><B>ITEM&nbsp;7.&nbsp;&nbsp;</B></P>
</TD><TD style="margin-top:0px" valign=top><P style="margin:0px"><B>MATERIAL TO BE FILED AS EXHIBITS.</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px; font-size:12pt">&nbsp;</P>
<P style="margin:0px">Exhibit A &#150; Loan documents pertaining to the borrowing of funds to finance the acquisition as disclosed in Item 3 (filed as an exhibit to a Schedule 13D on October 26, 2015, and incorporated herein by reference).</P>
<P style="margin-top:0px; margin-bottom:11.133px; font-family:Calibri,Times New Roman">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px" align=right>&nbsp;&nbsp;</P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px"><BR>
<BR></P>
<HR style="margin-bottom:9.6px; padding-top:9.6px" noshade size=1.333>
<P style="margin:0px; page-break-before:always"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD width=177.6 /><TD /><TD width=177.533 /></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" width=177.6><P style="margin:0px">CUSIP No.&nbsp; <B>03763A207</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF"><P style="margin:0px" align=center><B>13D</B></P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" width=177.533><P style="margin:0px" align=right>Page&nbsp;5&nbsp;of&nbsp;5 Pages</P>
</TD></TR>
</TABLE>
<P style="margin:0px; font-size:12pt">&nbsp;</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; font-size:12pt" align=center><B>SIGNATURE</B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.</P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-2px; width:48px; float:left">Dated:</P>
<P style="margin:0px; text-indent:-2px">April 5, 2016</P>
<P style="margin:0px; clear:left"><BR></P>
<TABLE style="margin-top:0px; font-size:10pt" cellpadding=0 cellspacing=0 width=100%><TR height=0 style="font-size:0"><TD /><TD width=29.067 /><TD width=250.267 /><TD width=85.4 /></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=279.333 colspan=2><P style="margin:0px"><B>Network Medical Management, Inc</B>.</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=85.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=29.067><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=250.267><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=85.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF; border-bottom:2.667px solid #FFFFFF" valign=top><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF; border-bottom:2.667px solid #FFFFFF" valign=top width=29.067><P style="margin:0px">By: </P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF; border-bottom:1px solid #000000" valign=top width=250.267><P style="margin:0px">&nbsp;/s/ Thomas Lam, M.D.</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF; border-bottom:2.667px solid #FFFFFF" valign=top width=85.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=29.067><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=bottom width=250.267><P style="margin:0px">Name: Thomas Lam, M.D.</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=85.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=29.067><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=250.267><P style="margin:0px; padding-left:36px; text-indent:-36px">Title: Chief Executive Officer</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=85.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
<TR><TD style="margin-top:0px; background-color:#FFFFFF" valign=top><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=29.067><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=250.267><P style="margin:0px">&nbsp;</P>
</TD><TD style="margin-top:0px; background-color:#FFFFFF" valign=top width=85.4><P style="margin:0px">&nbsp;</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
</BODY>
<!-- EDGAR Validation Code: 3D260E6F -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
